AI & Machine Learning Startups

CellaraRx develops Horizen, a platform that uses single-cell RNA sequencing, digital pathology, and AI to help clinicians and drug developers predict patient response to cancer treatments before clinical trial enrollment. The platform identifies tumor resistance mechanisms and tissue drug accessibility to improve patient stratification and trial success rates.

1 investor

CellaVision is a provider of digital hematology microscopy solutions including analyzers, instruments, reagents, and software that automate workflow in hematology laboratories. The company serves clinical and veterinary laboratories globally with digital cell morphology tools to minimize human error and streamline data management.

1 investor

The Cell engineers breakthrough medicines using molecular simulation and artificial intelligence to accelerate drug discovery and development.

1 investor

Cellcraft develops cultivated meat technology and bio-manufacturing systems that use AI and bioreactors to produce meat locally without animals. The company enables food producers to manufacture cultured meat tailored to local tastes while reducing environmental impact, antimicrobial resistance, and production costs.

1 investor

Cellectis is a biotech company focused on cell therapy and immunotherapy. The company is publicly listed on Nasdaq and Euronext Growth Paris.

1 investor

Cellergy develops allogeneic mitochondrial transplantation therapy, producing GMP-grade purified mitochondria from human primary cells for intravenous, repeated administration. Its therapy targets systemic and degenerative conditions such as CNS disorders, muscle degeneration, and aging, and uses a machine-learning model to predict donor/recipient matching.

1 investor

Cellpurics is a South Korean biotech company focused on stem cell technologies, including large-scale gonadal stem cell cultivation and storage, Real-time PCR-based measurement of mesenchymal stem cell anti-inflammatory capacity, and high-tech companion animal diagnostics. It also provides contract research organization (CRO) services covering in vitro and in vivo drug efficacy evaluation, veterinary drug and medical device clinical trials, GLP toxicity testing, and AI-based drug discovery.

1 investor

CellsBin develops an AI-driven photonic semiconductor platform for detecting, isolating, and characterizing rare cells in biological samples for therapeutic monitoring and precision medicine applications. The company serves researchers and clinicians in drug development, cell therapy monitoring, and clinical diagnostics.

1 investor

CELUS provides AI-driven automation software for electronics engineering, helping engineers design and develop electronic circuits faster. It targets electronics design and hardware engineering teams.

1 investor

Cenevo is a life science technology company that provides integrated lab management software combining electronic lab notebooks, LIMS, sample management, and AI-enabled automation for research organizations. The platform serves biotech firms, pharmaceutical companies, and research institutions seeking to streamline lab operations and accelerate scientific discovery.

1 investor

Cenote offers AI sales agents that contact direct-to-consumer online shoppers via phone and text to guide purchase decisions and recover abandoned transactions. The service addresses conversion gaps in e-commerce by maintaining ongoing conversations with potential buyers across multiple channels.

1 investor

CENT provides AI-powered financial solutions focused on sustainability. The company serves businesses seeking to integrate environmental considerations into their financial decision-making.

1 investor

Centari provides structured data infrastructure for law firms and investment funds to organize and leverage deal information across their organizations, enabling better business development and regulatory compliance.

1 investor

Centech provides engineering consulting, testing process design, IoT system integration, and equipment sourcing support for smart factory operations. It works with workshops and factories on operational architecture, pilot deployment roadmaps, technical team training, and monitoring dashboards.

1 investor

Centerfield is a marketing and customer acquisition company that uses proprietary technology and first-party data to run digital media buying and advertising campaigns for clients. It operates from offices in Los Angeles and Boston with remote staff.

1 investor

Centific is an AI and data company that builds platforms and services for enterprise AI teams, focused on data quality, workflows, evaluation, and multilingual and vision AI. It serves enterprise customers with data-centric AI development.

1 investor

Centinel is an AI platform that layers on top of existing ERP systems (NetSuite, Sage Intacct, QuickBooks) to run accounting workflows—procure-to-pay, AP/AR, reconciliation, close, controls, and error detection—using agents grounded in a company's own ledger, rules, and history. It targets finance teams at scaling companies handling growing transaction volumes without adding headcount, with a review-and-sign-off gate before anything posts to the ledger.

1 investor

Centraleyes offers an AI-powered cyber risk register and GRC platform that links risks to controls, compliance frameworks, evidence, remediation, vendor oversight, and executive reporting. It targets security, IT risk, compliance, and audit teams looking to run risk assessments and manage the full GRC lifecycle.

1 investor

CentralReach provides AI-powered software for autism and intellectual/developmental disability (IDD) care, serving applied behavior analysis practices, multidisciplinary clinics, and special education programs. The platform tech-enables care delivery across ABA, speech therapy, occupational therapy, and related services.

1 investor

Centrillion develops high-density DNA chips combined with AI-powered analysis to generate genomic and cellular data at scale for biological research. The platform enables researchers to ask thousands of variant questions in a single assay and decode genomes, cells, and tissues using AI models.

1 investor

Centrum-AI builds deterministic, explainable machine learning and risk-modeling systems to address supply chain uncertainty for global operations and enterprises. Drawing on a background in financial services, the company applies risk-modeling and compliance methods to supply chain intelligence.

1 investor

Cequence is an AI-powered contract lifecycle management platform that automates manual contract tasks and workflows while providing compliance tracking and analytics for enterprises of all sizes.

1 investor

Cera is Europe's largest HealthTech company building AI tools and digital products to predict hospitalizations and improve care delivery for NHS and government partners. The company rethinks healthcare delivery with a focus on keeping people healthier and out of hospital.

1 investor

Cerberus is a US company developing an AI agent for offensive security testing. The tool is positioned as an assistant for penetration testers and security teams, and the company states that formal methods are used to constrain the agent's actions so it cannot cause damage to the systems it tests.

1 investor